This brand name is authorized in United States. It is also authorized in Brazil, Canada, Ecuador, Hong Kong SAR China, Nigeria, Poland, Singapore, Tunisia, Turkey, UK.
The drug SURVANTA contains one active pharmaceutical ingredient (API):
1
|
UNII
S866O45PIG - BERACTANT
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| R07AA02 | Natural phospholipids | R Respiratory system → R07 Other respiratory system products → R07A Other respiratory system products → R07AA Lung surfactants |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 543714090000017, 543714090000117 |
| CA | Health Products and Food Branch | 02016109 |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 12-MBE-0614 |
| GB | Medicines & Healthcare Products Regulatory Agency | 80091 |
| HK | Department of Health Drug Office | 35445 |
| NG | Registered Drug Product Database | B4-9922 |
| PL | Rejestru Produktów Leczniczych | 100078677 |
| SG | Health Sciences Authority | 06720P |
| TN | Direction de la Pharmacie et du Médicament | 17603011H, 17603012H |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8680656080193 |
| US | FDA, National Drug Code | 0074-1040 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.